Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AMARIN CORP PLC\UK | President and CEO, Director | Ordinary Shares | 3.25M | $3.55M | $1.09 | Jul 30, 2021 | Direct |
Cyteir Therapeutics, Inc. | Director | Common Stock | 22.8K | $38.6K | $1.69 | Feb 8, 2024 | Direct |
AMARIN CORP PLC\UK | President and CEO, Director | Restricted Stock Units | 13.5K | Jul 30, 2021 | Direct | ||
CHIASMA, INC | Director | Stock Option (Right to Buy) | 0 | Aug 5, 2021 | Direct | ||
CinCor Pharma, Inc. | Director | Stock Option (Right to Buy) | 0 | Feb 24, 2023 | Direct | ||
Cyteir Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | Feb 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CYT | Cyteir Therapeutics, Inc. | Feb 8, 2024 | 2 | $21.7K | 4 | Feb 12, 2024 | Director |
CINC | CinCor Pharma, Inc. | Feb 24, 2023 | 2 | $0 | 4 | Feb 24, 2023 | Director |
CYT | Cyteir Therapeutics, Inc. | Feb 3, 2023 | 1 | $0 | 4 | Feb 7, 2023 | Director |
CYT | Cyteir Therapeutics, Inc. | May 10, 2022 | 1 | $20K | 4 | May 12, 2022 | Director |
CYT | Cyteir Therapeutics, Inc. | Feb 4, 2022 | 1 | $0 | 4 | Feb 7, 2022 | Director |
CYT | Cyteir Therapeutics, Inc. | Feb 4, 2022 | 0 | $0 | 3 | Feb 7, 2022 | Director |
CINC | CinCor Pharma, Inc. | Jan 6, 2022 | 0 | $0 | 3 | Jan 6, 2022 | Director |
CHMA | CHIASMA, INC | Aug 5, 2021 | 6 | $0 | 4 | Aug 5, 2021 | Director |
AMRN | AMARIN CORP PLC\UK | Jul 30, 2021 | 7 | -$43.9K | 4 | Aug 3, 2021 | President and CEO, Director |
AMRN | AMARIN CORP PLC\UK | Jun 30, 2021 | 7 | -$47.5K | 4 | Jul 2, 2021 | President and CEO, Director |
AMRN | AMARIN CORP PLC\UK | May 28, 2021 | 7 | -$48.1K | 4 | May 28, 2021 | President and CEO, Director |